Professor Lepore’s research group has long been thinking about cross-modal cortical reorganization and the usage of different sensory systems to pay for losses. Back 1998, Character published the team’s research on near-space auditory mapping by blind people. Earlier this full year, this same journal published another scholarly study by this group on superior tone discrimination abilities in the blind. The analysis published today may be the first showing that early – and late-onset blind people performed at related levels and much better than sighted people.We are planning an expanded safety research of Stedivaze in sufferers with asthma and COPD, while continuing to judge the efficacy and potential for superior tolerability of Stedivaze in our ongoing Phase III Factor 1 trial. ASNC2010 Presentation Summaries: A Randomized, Double-blind Placebo-controlled Study of the Protection of Apadenoson in Subjects with Mild or Moderate Asthma Presenters: Amy Lankford, Ph.Carol and D Reed, M.D., PGxHealth, a division of Clinical Data, Inc. Poster number 9# 9.12, Friday September 24, 2010, 11:45 a.m. – 1:15 p.m. In this Stage I, placebo-controlled study, Stedivaze was administered to 49 patients with slight to moderate asthma as an individual IV bolus, exactly like utilized in the ongoing Phase III Element 1 trial. Treatment with Stedivaze didn’t have any effects on pulmonary function and didn’t induce bronchoconstriction.